Home / Markets / Industries / Health Care
Wednesday, November 11, 2009
Sanofi-Aventis, Regeneron Expand Antibody Efforts
By Robert Daniel
MarketWatch Pulse
TEL AVIV -- Sanofi-Aventis, the Paris health-care giant, and Regeneron Pharmaceuticals Inc., the Tarrytown, N.Y., biopharmaceutical producer, expanded their effort to discover and market therapeutic monoclonal antibodies. Within the deal, Sanofi-Aventis will boost its funding commitment to $160 million a year from $100 million beginning in 2010. The funding commitment will now extend through 2017; the venture had been set to expire at the end of 2012. The companies aim to bring as many as five antibodies into clinical development each year, they said in a statement late on Tuesday. Since they formed their collaboration in November 2007, Sanofi Aventis and Regeneron have advanced four antibodies into clinical development and have filed for a fifth.
Copyright © 2009 MarketWatch, Inc.
Fox Business Video
-
-
The Crisis With 20/20 Hindsight
-
Nov 21, 2009
FOXBusiness.com LIVE
-
-
-
Jerry Rice Talks Career
-
Nov 21, 2009
NFL Receiver on career on the gridiron
-
-
-
John O'Hurley as Venture Capitalist
-
Nov 21, 2009
Comedian on life as venture capitalist
-
-
-
Excess Spending in Congress
-
Nov 21, 2009
Saving $100 Million
-
-
-
Cavuto Business Report 11-20-09
-
Nov 21, 2009
Business Report: Cavuto
-
